E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Add to balance / Manage account  User:  Log out
Prospect News home > News index > List of issuers S > Headlines for Savient Pharmaceuticals, Inc. > News item
Published on 9/24/2007 in the Prospect News Convertibles Daily and Prospect News High Yield Daily.

Savient Pharmaceuticals files $200 million shelf

By Devika Patel

Knoxville, Tenn., Sept. 24 - Savient Pharmaceuticals, Inc. filed a $200 million shelf registration in an S-3 filing with the Securities and Exchange Commission.

The registration covers common stock, preferred stock, debt securities and warrants. Notes may be convertible.

Proceeds will be used for general corporate purposes.

Savient is a pharmaceutical company located in East Brunswick, N.J.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.